The different role of YKL-40 in glioblastoma is a function of MGMT promoter methylation status

Inter- and intratumoral heterogeneity is a hallmark of glioblastoma (GBM) that facilitates recurrence, treatment resistance, and worse prognosis. O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation is a significant prognostic marker for Temozolomide (TMZ) resistance in GBM patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wei-jun, Zhang, Xiang, Han, Hua, Lv, Jian-nan, Kang, En-ming, Zhang, Yu-lian, Liu, Wei-ping, He, Xiao-sheng, Wang, James, Wang, Gui-huai, Yu, Yan-bing, Zhang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441403/
https://www.ncbi.nlm.nih.gov/pubmed/32820151
http://dx.doi.org/10.1038/s41419-020-02909-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441403/
https://www.ncbi.nlm.nih.gov/pubmed/32820151
http://dx.doi.org/10.1038/s41419-020-02909-9

Ejemplares similares